Background and aim: This study aimed to predict methylation status of the O-6 methyl guanine-DNA methyl transferase (MGMT) gene promoter status by using MRI radiomics features, as well as univariate and multivariate analysis.
Introduction:
Glioblastoma multiforms (GBM) are one of the most aggressive malignant brain tumors with an occurrence rate of 2 to 3 cases per 100,000 individuals (1). Post diagnosis, these patients have a median survival time of 15 months, with less than 5% of patients having a 5-year survival time (2) . This poor prognosis results from the intra-tumor genetic heterogeneous pattern of GBM (3).
Currently, temozolomide (TMZ) is the forefront in therapy for GBM patients. This treatment causes alkylation at the O-6 guanine of DNA, subsequently inducing cytotoxic effects and death in cancer cells (4) . Studies show that the methylation status of the O-6 methylguanine-DNA methyltransferase (MGMT) gene promoter could be a predictor for the efficacy of TMZ treatment (5) MGMT is a vital gene which encodes a DNA repair protein (6) . Tumor cells with MGMT expression show resistance to TMZ, while tumor cells without MGMT expression are more sensitive to TMZ. Demethylation of the DNA O-6 guanine by MGMT prohibits the DNA degradation induced by TMZ. GBM patients with MGMT promoter silencing show a higher response to TMZ. Several studies have shown that MGMT promoter methylation is associated with longer survival (7) (8) (9) .
In GBM patients without surgical resection indications, it has been shown that medical imaging could help understand the tumor pathology (10) . Clinical studies have indicated that magnetic resonance imaging (MRI) sequences such as T1, T1-contrast, T2, and FLAIR have a feasible role for the prognosis, diagnosis, and treatment plan for GBM (11) . Furthermore , further research studies have introduced radiomics as a novel field which can also be used as a powerful prognostic tool (12) (13) (14) . In combination with MRI sequences, these tools can have a major impact on GBM patient management through higher stratification (15) .
Radiomics is an advanced image processing technique which extracts a large number of quantitative features with standard and special algorithms. These features are then correlated with clinical outcomes. The features are shape, intensity, and texture based. The aforementioned features are used during clinical decision making for patient diagnosis, prognosis, and therapy response prediction/assessment (16) (17) (18) ). An extension of this field is radiogenomics, where radiomics features are correlated with genomics parameters (19) (20) (21) .
Tissue sampling with surgical resection is the gold-standard for the determination of MGMT promoter methylation status. However, this method has limitations such as GBM heterogeneity, a large volume of tissue specimens, and the cost of testing in clinics where it is not routine (22, 23) .
Recently, radiomics features have been used as imaging biomarkers in MGMT methylation status prediction (24, 25) . These quantitative features are reported to simplify the optimum tissue specimen at surgery (26) . Multiple studies have explored the efficacy of using these quantitative features in MGMT methylation status prediction. A study by Iliadis et al. (27) showed that necrosis volume is inversely associated with MGMT protein-positive tumor cells . Furthermore, a study by Levner et al used neural networks as a classifier with S-transform texture features acquired from MRI sequences (T2-w, FLAIR, and T1-w CE) and achieved over 87% accuracy for the prediction of MGMT methylation status (28) . Additionally, a study by Eoli et al reported that contrast enhanced regions of tumors are correlated with an unmethylated status (29). Moreover, a study by Drabycz et al evaluated Visually Accessible Rembrandt Images (VASARI) and automatic texture features for the prediction of MGMT methylation status. Their results revealed that incorporating VASARI with texture features improves the predictive power of MGMT methylation status (30) .
In another study, Moon et al. (24) found that there are several correlations between MGMT methylation status and features extracted from computed tomography (CT) and T2 * dynamic susceptibility, contrast enhanced perfusion-weighted imaging, and diffusion tensor imaging MRI features.
This present study aims to predict MGMT status by using T2W and T1W MRI radiomics features, along with univariate and multivariate analysis.
Material and Methods:
Figure 1 shows the process flow followed in the paper. 
GBM Patient Dataset
In this study, a total of 122 patients with pathologically confirmed GBM who had two MR images sequences (T2 fluid attenuation inversion recovery (FLAIR) and T1-W CE) were included. All images were downloaded from the cancer imaging archive (TCIA) (31, 32) . Clinical data from TCGA (33) and Bady et al. (34) were used to determine the MGMT methylation status using probe cg12434587 and cg12981137 values on HumanMethylation27 and HumanMethylation450 databases. Lastly, 82 patients who had a MGMT methylation status were kept in this study while the remainder of the data was excluded. Table 1 outlines the clinical characteristics of the patients included in this study. Thirteen shape features were extracted for each segment along with A/WT ratios, N/WT ratios, and WT/E ratios for the features. Texture sets were Gray Level Co-occurrence Matrix (GLCM),
Gray Level Run Length Matrix (GLRLM), Gray Level Dependence Matrix (GLDM), Gray Level
Size Zone Matrix (GLSZM), and Neighboring Gray Tone Difference Matrix (NGTDM) ( Table 1s in supplemental data). About 7047 features were extracted for each patient, and 41 image sets were prepared for model evaluations (Table 2s in supplemental data). 
Supplemental Table 1. Radiomics Features  First Order Statistics (FOS)  Gray Level Co-occurrence Matrix (GLCM)  Gray Level Run Length Matrix (GLRLM)
  Energy  Total Energy  Entropy  Minimum  10th percentile  90th percentile  Maximum  Mean  Median  Interquartile Range  Range  Mean Absolute Deviation (MAD)  Robust Mean Absolute Deviation (rMAD)  Root Mean Squared (RMS)  Standard Deviation  Skewness  Kurtosis  Variance  19. Uniformity   Autocorrelation  Joint Average  Cluster Prominence  Cluster Shade  Cluster Tendency  Contrast  Correlation  Difference Average  Difference Entropy  Difference Variance  Joint Energy  Joint Entropy  Informal Measure of Correlation (IMC) 1  Informal Measure of Correlation (IMC) 2  Inverse Difference Moment (IDM)  Inverse Difference Moment Normalized (IDMN)  Inverse Difference (ID)  Inverse Difference Normalized (IDN)  Inverse Variance  Maximum Probability  Sum Average  Sum Entropy  23. Sum of Squares   Short Run Emphasis (SRE)  Long Run Emphasis (LRE)  Gray Level Non-Uniformity (GLN)  Gray Level Non-Uniformity Normalized (GLNN)  Run Length Non-Uniformity (RLN)  Run Length Non-Uniformity Normalized (RLNN)  Run Percentage (RP)  Gray Level Variance (GLV)  Run Variance (RV)  Run Entropy (RE)  Low Gray Level Run Emphasis (LGLRE)  High Gray Level Run Emphasis (HGLRE)  Short Run Low Gray Level Emphasis (SRLGLE)  Short Run High Gray Level Emphasis (SRHGLE)  Long Run Low Gray Level Emphasis (LRLGLE)  16. Long Run High Gray Level Emphasis (LRHGLE)  Gray Level Dependence Matrix (GLDM)   Small Dependence Emphasis (SDE)  Large Dependence Emphasis (LDE)  Gray Level Non-Uniformity (GLN)  Dependence Non-Uniformity (DN)  Dependence Non-Uniformity Normalized (DNN)  Gray Level Variance (GLV)  Dependence Variance (DV)  Dependence Entropy (DE)  Low Gray Level Emphasis (LGLE)  High Gray Level Emphasis (HGLE)  Small Dependence Low Gray Level Emphasis (SDLGLE)  Small Dependence High Gray Level Emphasis (SDHGLE)  Large Dependence Low Gray Level Emphasis (LDLGLE)  14. Large Dependence High Gray Level Emphasis (LDHGLE)  Shape Features  Gray Level Size Zone Matrix (GLSZM)   Volume  Surface Area  Surface Area to Volume ratio  Sphericity  Compactness 1  Compactness 2  Spherical Disproportion  Maximum 3D diameter  Maximum 2D diameter (Slice)  Maximum 2D diameter (Column)  Maximum 2D diameter (Row)  Major Axis  Minor Axis  Least Axis  Elongation  Flatness  A/T volume ratio  N/T volume ratio  T/E volume ratio   Small Area Emphasis (SAE)  Large Area Emphasis (LAE)  Gray Level Non-Uniformity (GLN)  Gray Level Non-Uniformity Normalized (GLNN)  Size-Zone Non-Uniformity (SZN)  Size-Zone Non-Uniformity Normalized (SZNN)  Zone Percentage (ZP)  Gray Level Variance (GLV)  Zone Variance (ZV)  Zone Entropy (ZE)  Low  1-Coarseness  2-Contrast  3-Busyness  4-Complexity  5-Strength Supplemental
Feature selection
Seven different feature selections methods were used in the framework and performances were compared (see Table 2 ).
Classifiers Twelve Classifiers were implemented and compared ( Table 2 ). The details of each classifier are provided in Table 3s (supplementary).
Table 2. Feature selection and Classification methods -Evaluation
For univariate analysis, each feature value was normalized to obtain Z-scores, followed by student t-test students for comparison. A p-value of <0.05 was used as a criterion for statistically significant results. Area under the curve (AUC) of the receiver operating characteristic (ROC) curve was used to determine which feature could predict MGMT methylation status. Statistical analysis for this portion was performed in R 3.5.1 (using 'pROC' and 'stats' packages).
For multivariate analysis, an in-house developed python framework was used. A 10 fold crossvalidation (CV) was applied for model evaluation. Furthermore, the AUC of ROC curves were also used for model evaluations. Heat-maps and boxplots were constructed to compare different developed models. Lastly, the cross combinations of feature selections and classification methods were depicted as a heat-map (using mean AUC values in cross validation). Xi et al. (25) reported that combinations of sequences improved prediction performance as opposed to singular sequences. They found that T1-WI, T2-WI, and enhanced T1-WI radiomics features could predict MGMT promoter methylation with an accuracy of 86.59% in the training cohort and 80% in the validation cohort. This study extracted features from whole tumors, used SVM for classification, and LASSO for feature selection. Our results show that Bin 64 and LOG filter + shape features with combinations of four segments in T1w-CE and FLAIR has the best performance.
Feature Selection Methods
Furthermore, Wei et al. (38) reported that ADC values are correlated with MGMT methylation status. However, they also found that T1-W CE and T2 FLAIR sequences had better performances than ADC. Regarding the DWI, the extracted ADC value was found to be a predictor for MGMT promoter methylation status with a sensitivity of 84% and a specificity of 91%. Fusion radiomics signature model had the best performance. Our model performed well in the necrotic region when combining Bin, LOG, and WAV (BLW) filters.
In this study, multiregional segmentation was used for feature extraction in two MR sequences (Figure 1 ). Regions were also combined to investigate which ones have more prediction power ( Figure 5-a) . Additionally, the impact of MR image pre-processing and combining regions with differing MLs on the prediction of tumor MGMT mutation status was evaluated. However, this field lacks a comprehensive guideline for the optimal usage of robots features (39) (40) (41) , classifiers (14) . Therefore, this study attempted to determine the best classifier and feature selector for such investigations. Lastly, the impact of pre-processing MR images on MGMT methylation status determination was evaluated. The main limitation of this study was the size of the dataset. To overcome this limitation, models were validated using 10-fold cross-validation to reduce the sensitivity of the results to input data, as well as increase reliability. Future studies should use larger datasets that contain external validation sets.
Conclusion
This study showed that radiomics using machine learning algorithms is a feasible, noninvasive approach to predict MGMT methylation status in GBM cancer patients. Also, some radiomics could predict the issue alone or in combination with other features. This is important because it could narrow down the treatment options for patients and increase the safety and efficacy of the procedures.
